First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Catastrophic exposure creates a different kind of pressure. You are not just paying for treatment. You are managing a lifetime problem.
Critical incidents are unusually challenging events that overwhelm usual coping.
Is generic Nucynta IR and ER a new option for treating injured employees? Generic versions of Nucynta are now available in the U.S.
P&C leaders are feeling the mounting pressure to control overall claim spend in the face of rising medical costs, while maintaining access to c